Anatol J Cardiol. 2007; 7(Suppl 2): 5-8
2Department of Cardiology, Faculty of Medicine, Gazi University, Ankara
2Department of Cardiology, Faculty of Medicine, Gazi University, Ankara
Anahtar Kelimeler: Aspirin, diyabet, koroner arter hastalığı
Use of aspirin in diabetic patients
Sedat Türkoğlu1, Adnan Abacı21Department of Cardiology, Faculty of Medicine, Gazi University, Ankara, Turkey2Department of Cardiology, Faculty of Medicine, Gazi University, Ankara
Major cardiovascular events cause about 80% of the total mortality in diabetic patients. It has been shown that diabetic patients have hyperactive platelets. It may be expected that aspirin, through its antiplatelet action, could change the risk for vascular events in people with diabetes. However, some data suggest that aspirin may be less effective than expected in preventing cardiovascular events in patients with diabetes. In this paper, we review the aspirin use in diabetics with respect to cardiovascular endpoints.
Keywords: Aspirin, diabetes mellitus, coronary artery diseaseDiyabetik hastalarda aspirin
Sedat Türkoğlu1, Adnan Abacı21Department of Cardiology, Faculty of Medicine, Gazi University, Ankara, Turkey2Department of Cardiology, Faculty of Medicine, Gazi University, Ankara
Anahtar Kelimeler: Aspirin, diyabet, koroner arter hastalığı
Sedat Türkoğlu, Adnan Abacı. Use of aspirin in diabetic patients. Anatol J Cardiol. 2007; 7(Suppl 2): 5-8
Manuscript Language: English
Manuscript Language: English
Journal Metrics
Journal Citation Indicator: 0.18
CiteScore: 1.1
Source Normalized Impact
per Paper: 0.22
SCImago Journal Rank: 0.348
Quick Search
Copyright © 2024 The Anatolian Journal of Cardiology
Kare Publishing is a subsidiary of Kare Media.